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EndotheliumVascular endothelial cells (ECs) are responsible for post-ischemic angiogenesis, a process that is regulated by
reactive oxygen species. Recent studies indicate that endothelial Nox4 based NADPH oxidase may have a key
role. This study examines the role of endothelial Nox4 in ischemia-induced angiogenesis and explores the poten-
tial mechanisms involved. Mouse lines overexpressing human Nox4 wild type (EWT) or its dominant negative
form P437H (EDN) speciﬁcally in the endothelium were used. Non-transgenic littermate mice (NTg) were
used as controls. Following hind limb ischemia, blood ﬂow recovery was enhanced in EWT and was impaired
in EDN compared with NTg. The critical angiogenesis regulating genes vascular endothelial growth factor recep-
tor 2 (VEGFR2), endothelial nitric oxide synthase (eNOS) and transforming growth factor β1 (TGFβ1) were
upregulated in EWT both in the ischemic muscle and in heart ECs, while TGFβ1 was downregulated in EDN
ECs. In EC, both VEGFA and TGFβ1 stimulated EC proliferation, migration, and capillary-like network formation
in EWT but failed to do so in EDN. Application of TGFβ1 increased both VEGFR2 and eNOS expression levels,
whereas blocking TGFβ1 or addition of catalase inhibited the phosphorylation of VEGFR2 and eNOS, indicating
H2O2 and TGFβ1 signaling downstream of Nox4 is critical tomaintain EC angiogenic functions. Use of cell speciﬁc
transgenic mice with both upregulation and downregulation of endothelial Nox4 indicate several mechanisms
linked to Nox4 play a role in angiogenesis. Endothelial Nox4 regulates ischemia-induced angiogenesis, likely
through H2O2- and TGFβ1-mediated activation of cell signaling pathways essential for endothelial function.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Reactive oxygen species (ROS) are established signaling molecules
which regulate multiple cellular processes including proliferation,
differentiation, and apoptosis in response to stimulation by growth
factors, cytokines, and vasoactive agents. NADPH oxidases appear to
be the major contributors of ROS associated with cardiovascular health
and disease. The role of ROS in vascular diseases is complex. ROS have
been determined to induce and exacerbate vascular diseases. However,
inhibition of ROS formation has failed to prevent cardiovascular events
[1]. DifferentNADPHoxidase complexes are found to function in various
cardiovascular cells. This may exert opposing effects in different cell
types, such as in endotheliumversus in smoothmuscle. Although excess
ROS are generally believed toworsen disease, and our studies show thatincreased Nox4 worsens smooth muscle proliferative lesions [2–4],
recent studies suggest that Nox4 has protective effects in the endotheli-
um. In endothelial cells (ECs), both Nox2 and Nox4 are expressed. The
upregulation of Nox2 in the endothelium accounts for increased ROS
production, reduced nitric oxide (NO) bioavailability and early lesion
development in ApoE−/− mice [5]. Although Nox4 mRNA is more
abundant than Nox2 in the endothelium [6], the potential mechanisms
of endothelial Nox4 maintaining endothelial function have yet to be
elucidated. Recent publications suggest that hydrogen peroxide
(H2O2) produced by Nox4 is protective in the context of ischemia-
induced angiogenesis or angiotensin II-induced vascular dysfunction
[7–9]. Elevated endothelial Nox4 promotes angiogenesis and blood
ﬂow recovery from limb ischemia in an endothelial nitric oxide
synthase (eNOS)-dependent manner [7]; augments vasodilation and
decreases blood pressure [10]. Total bodyNox4−/−mice exhibit atten-
uated angiogenesis [9]. Compared to wild type animals, aortas from
inducible Nox4-deﬁcient animals had increased inﬂammation, medial
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Fig. 1. Nox4 expression and H2O2 production in transgenic mice. A. Endothelial speciﬁc
overexpression of human Nox4 co-localizes with endothelial marker von Willebrand
factor (vWF) in aorta from EWT. Only background staining was seen in NTg mouse aortic
sections. B. HumanNox4 relative copynumbers (corrected by beta-actin) in carotid artery.
n=4. C. Nox4 proteins levels in heart ECs. * or # p b 0.05 vs. NTg, n=3. D. H2O2 production
in heart ECs measured by Amplex Red. * or # p b 0.05 vs. NTg, n = 4.
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Loss of Nox4 decreased eNOS expression, NO production and heme
oxygenase-1 expression, andwas associatedwith apoptosis and inﬂam-
matory activation [9]. Notably, the effects of Nox4−/− in this casemay
not be limited to endothelial Nox4. Distinct from other members of the
NADPH oxidase family, Nox4 is believed to be constitutively active
and does not require cytosolic factors for its activation. Therefore, its
expression level determines the amount of ROS production in cells.
The multifarious functions of Nox4 in the vasculature is well described
in recent reviews [11,12].
Our study explores the fundamental roles of endothelial Nox4 in
regulating endothelial function in the context of angiogenesis and the
potential mechanisms involved by using transgenic mouse lines over-
expressing human Nox4 wild type (EWT) or its dominant negative
form P437H (EDN) in the endothelium driven by the Tie-2 promoter.
The proline at 437 is in the NADPH binding domain, and its substitution
with histidine abolishes ROS production. Furthermore, this mutation
functions as a dominant negative against endogenous Nox4 by
competing for the required interaction with p22phox [13]. We found
that endothelial Nox4 regulates ischemia-induced angiogenesis,
likely through H2O2- and transforming growth factor beta-1 (TGFβ1)-
mediated activation of cell signaling pathways essential for endothelial
function. Furthermore, endothelial Nox4 mediates the cell signaling
pathways regulated by vascular endothelial growth factor (VEGF). The
upregulation of adenosine monophosphate-activated protein kinase
alpha (AMPKα) phosphorylation and eNOS phosphorylation under
hypoxic conditions and the upregulation of VEGF receptor 2 (VEGFR2)
by endothelial Nox4may further contribute to the improved angiogenesis
following hind limb ischemia (HLI).
2. Materials and methods
2.1. Ethics statement
The protocol (AN 14148) concerning the use of animals was
approved by Institutional Animal Care and Use Committee of Boston
University Medical Center. All surgery was performed under ketamine
(100 mg/kg) and xylazine (20 mg/kg) anesthesia, and all efforts were
made to minimize suffering.
2.2. Generation of endothelial Nox4 transgenic mouse lines in FVB/N
background
Mouse lines overexpressing human Nox4 wild type or its dominant
negative form P437H in the endothelium driven by Tie-2 promoter
were originally generated in Dr. Junichi Sadoshima's laboratory on a
FVB/N genetic background. Nontransgenic littermate mice (NTg) were
used as controls.
2.3. Immunohistochemistry
Overexpression of Nox4 in the endothelium was conﬁrmed by
staining frozen aortic sections with a Nox4 antibody generated by
Dr. Sadoshima's group [13]. The mouse aorta was resected en bloc
with the surrounding tissue. Each aorta was embedded in Tissue-Tek
optimum cutting temperature compound and frozen in liquid nitrogen.
Five micrometer sections of aortic segments were prepared and
immunostained using a Nox4 monoclonal antibody or an endothelial
marker von Willebrand factor (vWF) polyclonal antibody (Abcam,
ab6994).
2.4. Heart endothelial cell isolation
Ventricles pooled from two hearts from each transgenic mouse line
were used for EC isolation from mice between 10 and 20 weeks of
age. At least 6 independent cell isolations were carried out for eachtransgenic mouse line along with age matched littermate controls.
Brieﬂy, ventricles were rinsed in Hank's balanced salt solution (HBSS),
and minced with 3000 U collagenase type II and 300 U DNAse I in
5mlHBSS. After incubation at 37 °Cwith gentle agitation for 30 minutes,
cell suspensions were ﬁltered through a 70 μm disposable cell strainer,
and then incubatedwith rat anti-mouse CD31 antibody (BD Biosciences
PharMingen) after lysis of red blood cells. ECs were isolated using goat
anti-rat IgG microbeads according to the manufacturer's instructions
(MACS Miltenyi Biotec, Inc). The resulting heart ECs were resuspended
in endothelial basal medium-2 (EBM-2) supplemented with 10% fetal
bovine serum (FBS), EC mitogen and antibiotics, and then placed on
gelatin coated dishes at a density of 2 ×104 cells per cm2. Cells frompas-
sages 2 to 8 were used. These cells had typical cobblestone appearance
and expressed EC antigens CD31 (PECAM), CD105 (Endoglin), CD145
and eNOS, and at passage 4 were 87% CD31 positive as determined by
ﬂow cytometry.
2.5. Amplex Red assay for ROS production
( [4]The H2O2-dependent oxidation of Amplex Red in cultured heart
ECs was measured by a microplate ﬂuorimeter (excitation/emission
540/580 nm).
2.6. Wounded monolayer migration assay in ECs
The detailed methods were published in smooth muscle cell and EC
[3,14,15]. Brieﬂy, heart ECs were seeded overnight in 0.2% FBS EBM-2 at
a density of 8 × 105 cells per well (conﬂuence) on 12-well plates coated
with gelatin. Scratch wounds were applied to EC monolayers with a
pipette tip. Immediately after scratching, the cells were treated with
vehicle or VEGFA (50 ng/mL) or TGFβ1 (50 ng/mL) in 0.2% FBS medium
and photographswere taken at 0 h and 6 h at three ﬁxed locations along
2491L. Chen et al. / Biochimica et Biophysica Acta 1842 (2014) 2489–2499the scratch with a light microscope and analyzed using NIH ImageJ
software.
2.7. Endothelial cell capillary-like network formation assay
[15]In vitro capillary-like network formation on VEGFA reduced
MatrigelTM (BD Biosciences) was assessed. Brieﬂy, 96-well plates were
coated with Matrigel according to the manufacturer's instructions. ECs
were seeded at 1 × 104 cells per well in EBM-2 supplemented with
0.2% FBS with or without VEGFA (50 ng/mL) or TGFβ1 (50 ng/mL) for
6 h. The images of the capillary-like network structure were taken and
the network formation index was determined by measuring the total
length of tubes using Wimasis Image analysis software.
2.8. Cell proliferation assay
Cells were seeded in 96-well plates at a density of 5 × ""103 cells per
well in EBM-2 supplemented with 0.2% FBS with or without VEGFA
(50 ng/mL) or TGFβ1 (50 ng/mL), and the cell number in each well
was determined at 24 h or 72 h after seeding. Culture medium with
or without growth factor was changed daily. A tetrazolium-based non-
radioactive proliferation assay kit (Quick Cell Proliferation Assay Kit II,
BioVision) was used to determine cell number according to the
manufacturer's protocol.NTg
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Fig. 2. The effect of endothelial Nox4 in blood ﬂow recovery after hind limb ischemia (HLI). A
Summary of blood ﬂow recovery of EWT,EDN and NTg mouse. * EWT (n = 14) or # EDN (n =
EWT (n = 15), NTg (n = 28) and EDN (n = 17). C. Aortic ring microvessel sprouting assay. A
grown from aortic ring was counted. * or # p b 0.05 vs. NTg, n = 5. D. The effects of endothe
HLI. Protein levels were corrected by GAPDH. * and # p b 0.05 vs. NTg, n = 5–8.2.9. Hind limb ischemia surgical procedure and laser Doppler perfusion
imaging
Mice at 12–16 weeks of age were subjected to unilateral hind
limb surgery under anesthesia with intraperitoneal administration of
ketamine (100 mg/kg) and xylazine (20 mg/kg). The left femoral artery
and vein were exposed, ligated with 6–0 silk ligatures and excised
immediately distal to the inguinal ligament and proximal to the poplite-
al bifurcation site. The right femoral artery and vein were similarly
manipulated but without ligation as a sham control. Laser Doppler
(from MoorLDL) was used to record perfusion of both the right and
left lower limbs before and immediately after surgery, followed by
measurements at 10 d, 21 d and 28 d. Mice were anesthetized and
placed on a heating plate at 37 °C to minimize temperature variation.
Excess hair was removed by depilatory cream from the limb before
imaging. Color-coded images were recorded. The blood ﬂow values
were expressed as the ratio of ischemic to nonischemic hind limb
perfusion. The gastrocnemius muscle was used for western blotting.
The clinical score at 28 days after femoral artery resection was assessed
as an index of severity of limb ischemia; the standards are as follows. 0:
normal; 1: pale foot or gait abnormalities; 2: less than half of foot
necrotic; 3: more than half of foot necrotic without lower limb necrosis;
4: more than half of foot necrotic with some lower limb necrosis; 5:
necrosis or autoamputation of entire lower limb.pre post 10d 21d 28d
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. Left: representative laser doppler perfusion images of EWT, EDN and NTg mouse. Right:
13) p b 0.05 vs NTg (n = 18). B. Clinical score 28 days after HLI. * or # p b 0.05 vs NTg,
ortic ring was cultured in Matrigel for 9 days and the number of sprouting microvessels
lial Nox4 on VEGFR2, eNOS and TGFβ1 in ischemic gastrocnemius muscle 28 days after
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[16] Mouse aortic ring outgrowth assays were performed as
previously described. Brieﬂy, the thoracic aorta was dissected and the
periaortic ﬁbroadipose tissue was removed under a stereo dissection
microscope using ﬁne tipped forceps and micro-dissection scissors,
then 1-mm long aortic rings were placed in 300 uL cold growth
factor-reduced Matrigel in a 48-well plate. After incubation a 37 °C for
20 minutes, 150 uL EBM-2 with 1% FBS was added, and the aortic
rings were incubated at 37 °C, 5% CO2 for 9 days for optimal micro-
vessel sprouting. Capillary sprouting was counted manually using
phase-contrast microscopy.2.11. Western blot analysis
Western blotting samples in Laemmli buffer with β-mercaptoethanol
were run on 10% electrophoresis gels. Proteins were transferred onto
supported PVDF membranes and blocked with 1% bovine serum
albumin (BSA). Primary antibodies were incubated overnight at 4 °C
in 1% BSA. Horseradish peroxidase-conjugated secondary antibodies
were used. Blots were imaged using ﬁlm. Antibody sources: VEGF
(sc-7269), VEGFR2 (sc-6251) and phospho-VEGFR2 (p-VEGFR2 at
Tyr1214, sc-101820) were from Santa Cruz Biotechnology; Nox4
(provided by Dr. Ajay Shah); eNOS (cat# 610297) and phospho-eNOS
(p-eNOS, Ser1177, cat# 612392) were from BD; AMPKα (cat# 2532),
phospho-AMPKα (p-AMPKα, Thr172, cat# 2531), p38mitogen activated
protein kinases (MAPK, cat# 2531), phospho-p38MAPK (p-p38MAPK,
Thr180/182, cat# 4511), protein kinase B (Akt, cat# 9272), phospho-
Akt (p-Akt, Ser473, cat# 9271), and GAPDH (cat# 2118) were fromVE
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2.12. Adenoviral transfection of human aortic endothelial cells (HAECs
[3] HAECs were transfected with empty adenoviral vector, human
Nox4 adenovirus (provided by Dr. Sadoshima[13]), adenoviral control
small interference RNA (siRNA) or adenoviral Nox4 siRNA (provided
by Dr. Chen[17]) with 50 MOI/cell in EBM-2 without serum or anti-
biotics for 6 h before switching to EBM-2 containing 2% FBS and growth
factors for 3 days.
2.13. Neutralizing antibodies
NTg heart ECs were cultured in 0.2%FBS EBM-2 with rabbit IgG or
VEGFR2 antibodies (Cell signaling, 200 ng/ml, cat# 2479) overnight.
HAECs were cultured in 0.2%FBS EBM-2 with mouse IgG or TGFβ1
antibodies (Sigma, 200 ng/ml, cat# T0438) overnight.
2.14. Hypoxic conditions
[18] Mouse heart ECs were seeded at a density of 2.5 × 106 per well
on 6-well plates in 0.2% FBS EBM-2 overnight before being changed to
10% FBS EBM-2 in normoxic or hypoxic conditions for 24 h. Hypoxic
conditionswere generated by a GasPak EZ gas generating pouch system
according to the manufacturer's instructions (BD Transduction Labora-
tories). This system induces anaerobic conditions of less than 2% oxygen
and more than 4% carbon dioxide by using carbon dioxide generating
reagents.p3
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PEG catalase was dissolved in PBS at 1 × 105 U/mL and applied to
cells at concentration 100U/mL. For EWTEC proliferation andmigration
assays, PEG catalase was added 24 h before and during assay. H2O2
(10 μmol/L), VEGFA (50 ng/mL) or TGFβ1 (50 ng/mL) were added to
culture media at different time points. For rescue experiments in EDN
ECs, 10–100 nM H2O2 was used.
2.16. Statistical analysis
All data were presented as mean ± SEM. One-way or two-way
ANOVA followed by repeated measures and post hoc analysis with
Bonferroni multiple comparison test were used to compare data from
the 3 groups with one or two treatments. A Student's t-test was used
to compare two groups. p b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Endothelial speciﬁc Nox4 mouse lines
The data shown in Fig. 1A indicate that the human Nox4 transgene
was speciﬁcally overexpressed in aortic endothelium compared with
NTg, co-localized with endothelial marker vWF. Copy numbers of
human Nox4 were similar in EWT and EDN carotid artery (Fig. 1B),while human Nox4 was undetectable in NTg mice because the chosen
primers are speciﬁc for human Nox4. There was no difference in the
endogenous mouse Nox4, other NADPH oxidase components (Nox2
and p22phox were abundantly expressed, while Nox1, Rac1, p47phox
and p67phox were less expressed or undetectable), antioxidant
enzymes (SOD1, SOD2, and catalase) in isolated heart ECs among
these transgenic mice (data not shown). In isolated heart ECs, Nox4
protein levels in EWT and EDN were increased about 2-fold compared
with NTg (Fig. 1C), EWT had higher H2O2 production by Amplex Red
assay whereas EDN had lower levels compared to NTg, conﬁrming the
dominant-negative functional effect of P437H on H2O2 production by
endogenous Nox4 (Fig. 1D).
3.2. The role of endothelial Nox4 in angiogenesis after hind limb ischemia
Next, the role of endothelial Nox4 in angiogenesis after HLI was
determined. As shown in Fig. 2A, EWT signiﬁcantly accelerated while
EDN signiﬁcantly delayed blood ﬂow recovery compared with NTg
after HLI. Additionally, a clinical scoring system was used to assess
lower-limb function and tissue health following surgery; the higher
the clinical score, the greater the severity of the ischemia. As shown in
Fig. 2B, EWT signiﬁcantly lowered while EDN signiﬁcantly increased
clinical scores compared with NTg, which correlates with the blood
ﬂow recovery data. Consistent with the in vivo data, the aortic ring
outgrowth assay (Fig. 2C), an in vitro angiogenesis model, indicated
that EWT enhanced and EDN impairedmicrovessel sprouting, conﬁrming
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trocnemius muscle, we evaluated factors that are critical for EC function.
As shown in Fig. 2D, the protein levels of VEGFR2, eNOS and TGFβ1
were upregulated in EWT compared with NTg. EDN upregulated TGFβ1
precursor while EWT showed a trend toward downregulating it. There
was no signiﬁcant difference in the VEGF levels. These results imply that
the stimulation of VEGFR2 and eNOS expression by endothelial Nox4
may be involved in maintaining EC function after damage.p-p38
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24 hours. B. Summary of band density in hypoxic condition. p-eNOS was corrected by
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or # p b 0.05 vs. NTg, n = 3–6.3.3. Angiogenesis related cell signaling pathways regulated by endothelial
Nox4 in cultured ECs
To gain evidence that the angiogenic regulatory factors noted above
in the ischemic gastrocnemius muscle originated in the endothelium,
we measured these factors in isolated heart ECs. As shown in Fig. 3A-
C, similar to what was found in ischemic gastrocnemius muscle, there
was nodifference in VEGF levels in ECs fromEWT, EDN andNTg, but sig-
niﬁcant increases in total VEGFR2, eNOS and TGFβ1 in both mRNA and
protein levels occurred in EWT. Although there was a decrease in
eNOS mRNA levels in EDN, there was no effect on total eNOS protein
levels which were very difﬁcult to detect in these microvascular ECs.
TGFβ1 precursor was downregulated by EWT, suggesting that endothe-
lial Nox4 might be involved in the process of TGFβ1 production.
Consistent with this, TGFβ1 mRNA level was upregulated in EDN, as
were levels of TGFβ precursor protein, whereas the active form of
TGFβ1 was decreased. The upregulation of TGFβ1 mRNA level by EDN
might reﬂect a feedback mechanism regulated by low TGFβ1 protein
levels. The upregulation of VEGFR2, eNOS and TGFβ1 in ischemic
gastrocnemius muscle from EWT is occurring in the endothelium.
In addition, we evaluated cell signaling pathways that promote cell
proliferation, migration, survival and network formation. As summa-
rized in Fig. 3B&C, though the total protein levels of Akt, AMPK and
p38 MAPK were not affected by EWT and EDN, EWT signiﬁcantly
increased the phosphorylation of eNOS (Ser1177), AMPKα (Thr172)
and p38 MAPK (Thr180/182) compared with NTg. Because total
eNOS is difﬁcult to detect at the right molecular weight, we corrected
p-eNOS to GAPDH. In comparison, EDN signiﬁcantly deceased thephosphorylation of VEGFR2 (Tyr1214), eNOS, Akt (Ser473), AMPKα
and p38 MAPK.
3.4. H2O2 and TGFβ1 mediate angiogenesis related cell signaling pathways
in cultured ECs
Because EWT increases H2O2 and TGFβ1 while EDN decreases them
in cultured ECs, PEG-catalasewas used to scavenge the product of Nox4,
H2O2, to test its role in regulating TGFβ1. As shown in Fig. 4A, applica-
tion of catalase for 2 h signiﬁcantly increased TGFβ1 precursor and
decreased active TGFβ1 levels in NTg ECs, indicating that the H2O2
level produced by endothelial Nox4 can play an important role in deter-
mining levels of active TGFβ1. Next, we tested the effects of H2O2 and
TGFβ1 on above cell signaling pathways and used VEGFA as a positive
control. As shown in Fig. 4B, application of H2O2 or TGFβ1, similar to
VEGFA, rapidly activated the phosphorylation of VEGFR2, Akt and p38
MAPK, aswell as a notable increase in eNOS andAMPKphosphorylation.
Interestingly, we found that application of PEG catalase decreased the
phosphorylation of eNOS and VEGFR2 after 24 h, but not of the other
proteins assessed (Fig. 4B). These data indicate that, in vitro, H2O2 or
TGFβ1 can activate the cell signaling pathways observed to be upregu-
lated in EWT, and that catalase can mimic some, but not all, effects
observed in EDN. Because we observed a consistent increase of
VEGFR2 and eNOS in both ischemic limb muscle and cultured heart
ECs from EWT, we tested whether VEGFR2 mediated responses could
regulate eNOS. As shown in Fig. 4C, blocking VEGFR2 with neutralizing
antibodies overnight signiﬁcantly decreased total eNOS and eNOS
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EWT ECs (data not shown). This result indicates that VEGFR2 regulates
eNOS expression, and that upregulated eNOS in EWTmight therefore be
linked to the increased VEGFR2.
3.5. VEGFA mediated angiogenesis related cell signaling pathways in
cultured ECs.
Because VEGFR2 is the major VEGFA receptor to regulate EC
functions, and EWT signiﬁcantly increased VEGFR2 level, we tested
the above cell signaling pathways in ECs of the three groups with
VEGFA stimulation. As summarized in Fig. 5, VEGFA at 10 min signiﬁ-
cantly stimulated the above cell signaling pathways in NTg and EWT,
but had less effect on EDN. In addition, the phosphorylation of eNOS
and AMPK were signiﬁcantly enhanced in EWT but were signiﬁcantly
decreased in EDN compared with NTg. This indicates that endothelial
Nox4 mediates the above cell signaling pathways stimulated by
VEGFA, contributing to VEGFA-induced angiogenesis.
3.6. Cell signaling pathways under hypoxic conditions
Tomimic the conditions of HLI,we also evaluated these angiogenesis
related cell signaling pathways under hypoxic conditions in vitro.
As shown in Fig. 6A, in NTg ECs, 24 h of hypoxia downregulated the
phosphorylation of Akt, AMPKα, p38 MAPK and eNOS compared
with normoxic conditions in 10% FBS medium. As summarized in
Fig. 6B, under hypoxic conditions, EWT had signiﬁcantly higher
phosphorylation levels of eNOS and AMPK. In comparison, EDN signiﬁ-
cantly downregulated the phosphorylation of Akt, AMPKα and eNOS.Phosphorylation of p38 MAPK was not signiﬁcantly affected. The
regulation of these cell signaling pathways under hypoxic conditions
may contribute to the outcomes of the in vivo angiogenesis after HLI.
3.7. The roles of endothelial Nox4 in proliferation, migration and
network formation
Because the upregulated VEGFR2 and eNOS by EWT are important
downstream targets of VEGFA, and TGFβ1 was inversely regulated in
EWT and EDN, we evaluated the roles of Nox4 in regulating endothelial
function in isolated heart ECs in both baseline and growth conditions.
Since ECs did not proliferate without growth factors, we tested EC
proliferation under VEGFA or TGFβ1 stimulation. As shown in Fig. 7A-
C, both VEGFA and TGFβ1 stimulated cell proliferation, migration, and
capillary-like network formation in EWT but failed to do so in EDN.
EWT also signiﬁcantly increased the basal cell migration rate and
capillary-like network formation, while EDN decreased basal capillary-
like network formation compared with NTg. These results indicate
that endothelial Nox4 is not only important for maintaining basal EC
function, but is also critical in growth factor induced EC growth. Similar
to VEGFA, TGFβ1 is also an important angiogenesis factor from our
studies.
3.8. Application of H2O2 improves EDN EC proliferation and migration
Next, we tested whether adding H2O2 could improve angiogenesis
in EDN ECs. As shown in Fig. 8A, adding H2O2 at concentration
from 10–100 nM could improve EDN EC proliferation and migration.
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3.9. Application of PEG catalase has no effect on TGFβ1 induced EWT EC
proliferation and migration
In EWT ECs, as shown in Fig. 8B, pretreatement of PEG catalase for
24 h could suppress serum induced cell proliferation and basal cell
migration, but had no effect on TGFβ1 induced cell proliferation and
migration, indicating the effect of TGFβ1 could be independent of H2O2.
3.10. The effects of Nox4 in HAECs
To assess whether ﬁndings in the mouse EC were affected by the
required culture and passage before study, we used adenovirus to over-
express human Nox4 wild type and Nox4 siRNA to downregulate Nox4
in HAECs, and the overexpression and downregulation were conﬁrmed
by western blot (Fig. 9A). Overexpression of human Nox4 signiﬁcantly
increased VEGFR2, eNOS and TGFβ1 (Fig. 9B), while downregulation
of Nox4 signiﬁcantly inhibited VEGFR2 and TGFβ1 (Fig. 9C). As shown
in Fig. 9D, overexpression of Nox4 dose-dependently increased
VEGFR2, eNOS and eNOS phorphorylation. Overexpression of Nox4
increased capillary-like network formation, while downregulation
of Nox4 decreased network formation (Fig. 9E), conﬁrming that the
pathways regulated in EWT and EDN EC had similar pro-angiogenic
roles in HAEC.3.11. The effects of TGFβ1 on VEGFR2 and eNOS in HAECs
Because of the consistent ﬁndings in EC from transgenic mice and
cultured HAECs, the role of TGFβ1 in the increased levels of VEGFR2
and eNOS induced by overexpression of Nox4 in HAECwas determined.
As shown in Fig. 10A, application of TGFβ1 (10 ng/mL) overnight
signiﬁcantly increased both VEGFR2 and eNOS protein levels. Similar
to what we found in smooth muscle cells, application of TGFβ1 can
also increased endothelial cell Nox4 protein levels (Fig. 10A). TGFβ1
neutralizing antibodies signiﬁcantly inhibited the phosphorylation of
VEGFR2 and eNOS, though there was no effect on their total protein
levels (Fig. 10B).
4. Discussion
Using ECs directly cultured from transgenic animals avoids multiple
confounding variables, including those related to use of adenoviral
vectors. This is the ﬁrst paper using transgenic mice to show the effects
of both up- and down-regulation of endothelial Nox4 on angiogenesis,
and to explore the effects on the crucial cell signaling pathways that
regulate endothelial function in cultured ECs from these endothelial
speciﬁc Nox4 mouse lines.
Our studies show that the phosphorylation of eNOS at Ser1177 is up-
and down- regulated by EWT and EDN, lending support to the conclu-
sion a major effect of EC Nox4 is the regulation of eNOS function [7,9].
The major new ﬁndings from our study show important contributions
of VEGFR2 and TGFβ1 by Nox4. The potential mechanisms we propose
are: 1) A modest elevation in Nox4 expression in the endothelium
increases both H2O2 and TGFβ1 to activate cell signaling pathways
involvingVEGFR2, eNOS, p38MAPK andAMPKα, which in turn regulate
cell proliferation, migration, network formation to improve angiogene-
sis. In contrast, downregulation of endothelial Nox4 decreases both
H2O2 and TGFβ1, and downregulates the above cell signaling pathways,
especially on VEGFR2 and eNOS, and impairs EC function and leads
to impaired angiogenesis; 2) The increased TGFβ1 in EWTmay directly
upregulate both VEGFR2 and eNOS to further contribute to the
improved angiogenesis; 3) Endothelial Nox4 mediates VEGFA induced
cell signaling pathways and may contribute to the VEGFA induced
angiogenesis; 4) Under hypoxic conditions, EWT signiﬁcantly increases
the phosphorylation of eNOS and AMPKα to improve EC survival and to
improve angiogenesis. In contrast, EDN signiﬁcantly downregulates
their phosphorylation and leads to impaired angiogenesis. As summa-
rized in Fig. 11, our hypothesis is that endothelial Nox4 through
its regulation on H2O2 mediates TGFβ1 production, which in turn
upregulates Nox4 to further contribute to angiogenesis response by
regulating angiogenesis related cell signaling pathways.
Although we did not observe regulation of VEGFA expression by up-
or down-regulation of EC Nox4, our recent publication indicates that
Nox4 is required for VEGFA-induced calcium inﬂux, migration and
network formation in HAECs [14]. As suggested by our ﬁndings the
underlying mechanism is likely through VEGFR2-mediated cell signal-
ing pathways, especially involving the phosphorylation of eNOS and
AMPKα.
VEGFR2 is the key receptor mediatingmost cellular effects of VEGFA
in the endothelium. VEGFR2 deﬁcient mice die in utero due to impaired
vasculogenesis [19]. One of the new ﬁndings of our study is that VEGFR2
is signiﬁcantly upregulated by EWT in both ischemic gastrocnemius
muscle and cultured mouse ECs, and after overexpression of human
Nox4 in HAECs. Although we did not see downregulation of VEGFR2
by EDN, thephosphorylation of VEGFR2 at Tyr1214was signiﬁcantly de-
creased in EDN, by PEG catalase, and by TGFβ1 neutralizing antibodies,
indicating that downregulation of endothelial Nox4 suppresses VEGFR2
function through H2O2 and TGFβ1. Application of TGFβ1 upregulated
both VEGFR2 and eNOS, while blocking VEGFR2 suppressed eNOS
protein levels, consistent with VEGFR2 regulating eNOS. Both PEG
catalase and antagonizing TGFβ1 suppressed the activation of VEGFR2
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of VEGFR2 and eNOS. The upregulation of VEGFR2 by EC Nox4may con-
tribute to improved angiogenesis after HLI and in vitro EC proliferation,
migration and network formation.
Although TGFβ1 is awell-known activator of Nox4 in smoothmuscle
cells, one of the important new ﬁndings of our study is that Nox4 can
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esis could be independent of each other. TGFβ1 maintains arterial
maturation by regulating smooth muscle cell and EC growth. Targeted
disruption of TGFβ1 and its receptor genes in mice led to embryonic
lethality due to defective vascular development [21–23]. TGFβ1 induces
vessel maturation, promotes basement membrane deposition, and
enhances the interactions between ECs and mural cells [24,25]. In addi-
tion, TGFβ1 stabilizes capillary-like networks in a three-dimensional
model of in vitro angiogenesis [26] and promotes the formation of
new blood vessels by employing a chick chorioallantoic membrane
assay [27]. In ECs, TGFβ1 can induce eNOS transcription via Smad2
dependent- and independent- pathways [28,29]. Thus, the upregulation
of TGFβ1 in EWTmay contribute to the increased levels of eNOS in both
ischemic gastrocnemius muscle and cultured ECs. Our study indicates
that application of TGFβ1 also signiﬁcantly increases eNOS in HAECs.
We found that EWT decreased TGFβ1 precursor and increased active
TGFβ1 protein levels, indicating that endothelial Nox4 regulates the
conversion of TGFβ1 precursor to the active form of TGFβ1. This is
supported by our ﬁnding that application of catalase increased TGFβ1
precursor level and decreased the active form of TGFβ1 level, indicating
that the H2O2 produced by endothelial Nox4 is required for the conver-
sion of TGFβ1 precursor to its active form. The potential mechanisms of
conversion of TGFβ1 precursor to the active form of TGFβ1, which are
well summarized in a review [30], includes the oxidation of latency-
associated peptide causing loss of its non-convalent association with
the active form of TGFβ1 by ROS [30]. The exact mechanisms of how
Nox4 regulates TGFβ1 production warrant further investigation.
Under hypoxic conditions, overexpression of EC Nox4 signiﬁcantly
increases the phosphorylation of eNOS and AMPKα. The activation of
AMPKα is speciﬁcally required for EC migration and differentiation
under conditions of hypoxia in human umbilical vein EC in which
suppression of AMPKα signaling inhibited both migration to VEGF and
differentiation into capillary-like networks in hypoxic cultures [18].
In ECs exposed to hypoxia and glucose deprivation, activation of
AMPKα1, but not AMPKα2 suppresses apoptosis by increasing NFκB-
mediated expression of anti-apoptotic proteins (Bcl-2 and survivin) as
well as intracellular ATP content [31]. Although we could not separate
which subtype was upregulated by Nox4, the upregulation of AMPKα
phosphorylation by EC Nox4 under hypoxic conditions likely to be
very important for EC survival and the improved angiogenesis after HLI.
The limitation of this study is that the regulation of angiogenesis in
our Nox4 transgenic mice may not be due only to the endothelial
Nox4, as the Tie 2 promoter we used to drive Nox4 overexpression is
not restricted to ECs. Tie2, an angiopoietin receptor, is mainly expressed
in ECs, but it is also expressed in hematopoietic stem cells and mono-
cytes that exist in bone marrow and peripheral blood [32]. As data notshown here, we did ﬁnd human Nox4 constructs were expressed
in bone marrow derived macrophage and in peripheral monocyte. Al-
though we could not decipher the contribution of Nox4 in these cells
of non-endothelial origin to angiogenesis in current studies, the effects
of Nox4 on endothelial function and cell signaling pathways in cultured
ECs support the notion that endothelial Nox4 is one of the key players in
angiogenesis. Bone marrow transplant studies will further elucidate
whether the Nox4 in cells of non-endothelial origin also contribute to
angiogenesis.
In summary, EC Nox4 regulates ischemia-induced angiogenesis,
likely through H2O2- and TGFβ1-mediated cell signaling pathways
essential for EC function. TGFβ1 is an important mediator of EC
Nox4 in regulating the expression and function of VEGFR2 and eNOS.
The increased phosphorylation of eNOS and AMPKα under hypoxic
conditions as well as the increased expression of VEGFR2 and eNOS
associated with increased EC Nox4 may further contribute to the
improved angiogenesis after HLI.
The signiﬁcance of this study lies in informing the development of
therapeutic interventions to improve endothelial function and angio-
genesis. From a clinical perspective, this research will advance our
understanding of angiogenesis, which may consequently lead to the
development of selective activators/inhibitors of EC Nox4 and/or its
downstream targets as novel therapeutics for cardiovascular disease,
particularly in angiogenesis. Additionally, ﬁndings from our studies
may be applicable to themore general problem of impaired EC function
associated with cardiovascular disease.
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